Remdesivir doesn’t help COVID-19 patients recover, WHO study says.

Click to play video 'Coronavirus: WHO says Remdesivir not effective in preventing death from COVID-19, trial to assess other antibodies'

WATCH: The World Health Organization Director-General Tedros Adhanom Ghebreyesus said on Friday that WHO’s COVID-19 solidarity trial found Gilead Science's Remdesivir had no impact on survival rates, adding that it would assess monoclonal antibodies and other antiviral drugs in its trial of potential COVID-19 treatments. – Oct 16, 2020

GENEVA — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries.

The results announced Friday do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival.

The drug has not been approved for COVID-19 in the U.S., but it was authorized for emergency use after the previous study found it shortened recovery time by five days on average. It’s approved for use against COVID-19 in the United Kingdom and Europe, and is among the treatments U.S. President Donald Trump received when he was infected earlier this month.

The WHO study involved more than 11,000 patients in 30 countries. About 2,750 were randomly assigned to get remdesivir. The rest got either the malaria drug hydroxychloroquine, the immune-system booster interferon, the antiviral combo lopinavir-ritonavir, or just usual care. The other drugs have largely been ruled out for COVID-19 by previous studies, but not remdesivir.

Death rates after 28 days, the need for breathing machines and time in the hospital were relatively similar for those given remdesivir versus usual care.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

The results have not been published in a journal or reviewed by independent scientists, but were posted on a site researchers use to share results quickly.

“The big story is the finding that remdesivir produces no meaningful impact on survival,” Martin Landray, an Oxford University professor who led other coronavirus treatment research, said in a statement.

Trending Stories

“This is a drug that has to be given by intravenous infusion for five to 10 days,” and costs about $2,550 per treatment course, he said. “COVID affects millions of people and their families around the world. We need scalable, affordable and equitable treatments.”

Dr. Margaret Harris, a WHO spokeswoman, attributed the difference in the conclusions of the two studies to the fact WHO’s was larger.

“It’s just a much higher-powered study,” she said. “It’s quadruple the number of people in all the other studies.”

However, Dr. Andre Kalil, a University of Nebraska infectious disease specialist who helped lead the U.S. remdesivir study, said the WHO one was poorly designed, which makes its conclusions less reliable. Patients and doctors knew what treatment they were using, there was no placebo infusion to help avoid biased reporting of risks or benefits, there was little information about the severity of patients’ symptoms when treatments began and a lot of missing data, he said.

“Poor quality study design cannot be fixed by a large sample size, no matter how large it is,” Kalil wrote in an email.

Furthermore, the WHO study tested 10 days of remdesivir, so some patients may have been hospitalized longer than they needed to be just to finish treatment, making their length of stay look bad in comparison to others getting usual care.

Remdesivir’s maker, Gilead Sciences, said in a statement that the results are inconsistent with more rigorous studies and have not been fully reviewed or published.

View link »

© 2020 The Canadian Press

Global News

Breaking news & current latest Canadian news headlines; national weather forecasts & predictions, local news videos, money and financial news; sports stats and scores.

https://globalnews.ca/

Related news
Pamela Brown presses GOP lawmaker: What was your research on voter fraud claims?.

Pamela Brown presses GOP lawmaker: What was your research on voter fraud claims?.

CNN's Pamela Brown presses Rep. Madison Cawthorn (R-NC) about his pledge to work with the Biden administration despite voting to decertify the results of the 2020 presidential election. #CNN #News

COVID-19: 'We're a long, long way from easing restrictions'.

COVID-19: 'We're a long, long way from easing restrictions'.

Health Secretary Nick Hancock has warned that infections will have to fall a 'long, long way' for restrictions to be lifted in England. Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí SUBSC...

Labour calls for 'comprehensive' COVID-19 quarantine system for travellers.

Labour calls for 'comprehensive' COVID-19 quarantine system for travellers.

Shadow Home Secretary Nick Thomas-Symonds says the Government should have slapped down border controls last year on travellers arriving in the UK. Speaking on the Sophy Ridge on Sunday show, he described the Government's response as 'chaotic'. SUB...

COVID-19: Delaying 2nd Pfizer jab is an 'unregulated and unlicensed' trial.

COVID-19: Delaying 2nd Pfizer jab is an 'unregulated and unlicensed' trial.

A GP in the Doctors' Association explains why they are 'concerned' about delaying the second dose of the Pfizer vaccine. Patients have been told they'll have to wait 12 weeks between the two jabs, longer than the manufacturer recommends. The decis...

Navalny supporters arrested during mass protests in Russia.

Navalny supporters arrested during mass protests in Russia.

Roughly 2,250 people have reportedly been arrested at a series of demonstrations in support of the jailed Putin critic Alexei Navalny across Russia. The gatherings, which police have declared illegal, are the first by Mr Navalny's supporters since...

Arlene Foster dismisses support for Northern Ireland referendum.

Arlene Foster dismisses support for Northern Ireland referendum.

DUP leader Arlene Foster has dismissed a poll showing growing enthusiasm for a referendum on the future of Northern Ireland. She also discussed NI's latest response to COVID-19. Speaking on the Sophy Ridge on Sunday show, he described the Governme...

1 2